FMC Corporation (FMC)
Why Is FMC (FMC) Down 9.9% Since Last Earnings Report?
FMC (FMC) reported earnings 30 days ago. What's next for the stock?
Is the Options Market Predicting a Spike in FMC Stock?
Investors need to pay close attention to DAKT stock based on the movements in the options market lately.
Unlocking FMC (FMC) International Revenues: Trends, Surprises, and Prospects
Evaluate FMC's (FMC) reliance on international revenue to better understand the company's financial stability, growth prospects and potential stock price performance.
FMC (FMC) Q2 Earnings: Taking a Look at Key Metrics Versus Estimates
While the top- and bottom-line numbers for FMC (FMC) give a sense of how the business performed in the quarter ended June 2026, it could be worth looking at how some of its key metrics compare to Wall Street estimates and year-ago values.
FMC Q2 Earnings Call Highlights
FMC NYSE: FMC reported second-quarter revenue of $841 million excluding India, below the low end of its guidance range, as cautious customer purchasing, unfavorable weather, low insect pressure and pricing pressure weighed on demand. However, adjusted EBITDA of $153 million exceeded the high end of management's guidance by 2%, aided by cost discipline and favorable quarter-specific items.
FMC Corporation (FMC) Q2 2026 Earnings Call Transcript
FMC Corporation (FMC) Q2 2026 Earnings Call Transcript
FMC Q2 Earnings Beat Estimates on Favorable Costs, Revenues Miss
FMC's Q2 earnings beat estimates as cost gains offset weaker pricing and volumes. Revenues declined and 2026 sales guidance was cut.
FMC (FMC) Tops Q2 Earnings Estimates
FMC (FMC) came out with quarterly earnings of $0.26 per share, beating the Zacks Consensus Estimate of $0.21 per share. This compares to earnings of $0.69 per share a year ago.
Analysts Estimate FMC (FMC) to Report a Decline in Earnings: What to Look Out for
FMC (FMC) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.
FMC Files First Global Regulatory Submission With EPA for Rimisoxafen
FMC's first global dossier for rimisoxafen seeks U.S. approval for a dual-action herbicide aimed at tough broadleaf weeds in major crops.
FMC Lands $400M Minority Investment From Tessenderlo Group
FMC secures a $400 million investment from Tessenderlo Group to cut debt, strengthen liquidity and support crop protection technology growth.
FMC to Sell Newark Property for $114M, Use Proceeds to Cut Debt
FMC plans a $114M Newark property sale to cut debt, retain key R&D operations and keep its Stine Research Center fully intact.
